ConductScience.org, home

Paper28293038

Naphthacemycins, novel circumventors of β-lactam resistance in MRSA, produced by Streptomyces sp. KB-3346-5. I. The taxonomy of the producing strain, and the fermentation, isolation and antibacterial activities.

Fukumoto A and 11 others. J Antibiot (Tokyo), 2017. Cited by 24 papers, by iCite.

Cite this record

ConductScience Library. Naphthacemycins, novel circumventors of β-lactam resistance in MRSA, produced by Streptomyces sp. KB-3346-5. I. The taxonomy of the producing strain, and the fermentation, isolation and antibacterial activities. Papers, record 28293038. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28293038

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Naphthacemycins, novel circumventors of β-lactam resistance in MRSA, produced by Streptomyces sp. KB-3346-5. I. The taxonomy of the producing strain, and the fermentation, isolation and antibacterial activities.
PubMed
Journal
J Antibiot (Tokyo)
PubMed
Year
2017
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
24
iCite
Relative citation ratio, by iCite
1.17
iCite
Revised in PubMed
2026-10-10
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fukumoto AAtsushi
2Kim YPYong-Pil
3Matsumoto AAtsuko
4Takahashi YYoko
5Suzuki MMakoto
6Onodera HHideyuki
7Tomoda HHiroshi
8Matsui HHidehito
9Hanaki HHideaki
10Iwatsuki MMasato
11Ōmura SSatoshi
12Shiomi KKazuro

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
ImipenemMajor topic
Methicillin-Resistant Staphylococcus aureusMajor topic
StreptomycesMajor topic
Chromatography, High Pressure Liquid
Drug Design
Drug Synergism
Microbial Sensitivity Tests
beta-Lactam Resistance
beta-Lactams

Source PubMed

Download CSV of topics

References16

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111347972Microbial fermentation-derived inhibitors of efflux-pump-mediated drug resistance.Farmaco2001https://conductscience.org/library/papers/11347972PubMed
2485765[Metabolic products of microorganisms. 175. Tetracenomycin C (author's transl)].Arch Microbiol1979https://conductscience.org/library/papers/485765PubMed
318305353Cyslabdan, a new potentiator of imipenem activity against methicillin-resistant Staphylococcus aureus, produced by Streptomyces sp. K04-0144. II. Biological activities.J Antibiot (Tokyo)2008https://conductscience.org/library/papers/18305353PubMed
418936894Final report from the Committee on Antimicrobial Susceptibility Testing, Japanese Society of Chemotherapy, on the agar dilution method (2007).J Infect Chemother2008https://conductscience.org/library/papers/18936894PubMed
515516341Determination of selectivity and efficacy of fatty acid synthesis inhibitors.J Biol Chem2005https://conductscience.org/library/papers/15516341PubMed
621768346Functional analysis of environmental DNA-derived type II polyketide synthases reveals structurally diverse secondary metabolites.Proc Natl Acad Sci U S A2011https://conductscience.org/library/papers/21768346PubMed
728293036Naphthacemycins, novel circumventors of β-lactam resistance in MRSA, produced by Streptomyces sp. KB-3346-5. II. Structure elucidation.J Antibiot (Tokyo)2017https://conductscience.org/library/papers/28293036PubMed
818585915The role of virulence determinants in community-associated MRSA pathogenesis.Trends Microbiol2008https://conductscience.org/library/papers/18585915PubMed
98031024Tetracycline analogs whose primary target is not the bacterial ribosome.Antimicrob Agents Chemother1994https://conductscience.org/library/papers/8031024PubMed
1022224500Environmental DNA-encoded antibiotics fasamycins A and B inhibit FabF in type II fatty acid biosynthesis.J Am Chem Soc2012https://conductscience.org/library/papers/22224500PubMed
11894261Distribution of menaquinones in actinomycetes and corynebacteria.J Gen Microbiol1977https://conductscience.org/library/papers/894261PubMed
1218305352
Cyslabdan, a new potentiator of imipenem activity against methicillin-resistant Staphylococcus aureus, produced by Streptomyces sp. K04-0144. I. Taxonomy, fermentation, isolation and structural elucidation.
J Antibiot (Tokyo)2008https://conductscience.org/library/papers/18305352PubMed
1319862477The tetracycline resistome.Cell Mol Life Sci2010https://conductscience.org/library/papers/19862477PubMed
1423157252Tetarimycin A, an MRSA-active antibiotic identified through induced expression of environmental DNA gene clusters.J Am Chem Soc2012https://conductscience.org/library/papers/23157252PubMed
1516180833Anthrabenzoxocinones from Streptomyces sp. as liver X receptor ligands and antibacterial agents.J Nat Prod2005https://conductscience.org/library/papers/16180833PubMed
161429222Benastatins A and B, new inhibitors of glutathione S-transferase, produced by Streptomyces sp. MI384-DF12. I. Taxonomy, production, isolation, physico-chemical properties and biological activities.J Antibiot (Tokyo)1992https://conductscience.org/library/papers/1429222PubMed

Download CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.

PMIDTitleJournalYearIn PapersSource
41988676Using X-ray Crystallography and 1,n-ADEQUATE NMR to Revise the Structures of Highly Substituted Aromatic Natural Products: The Absolute Configuration of Formicamycin Congeners.J Nat Prod2026https://conductscience.org/library/papers/41988676PubMed
40104604Mangrove pneumatophores as biocatalysts for the fabrication of silver nanoparticles and their potential applications against biofilm formation and hepatic carcinoma.Nanoscale Adv2025https://conductscience.org/library/papers/40104604PubMed
39265189Total Synthesis of the Phenylnaphthacenoid Type II Polyketide Antibiotic Formicamycin H via Regioselective Ruthenium-Catalyzed Hydrogen Auto-Transfer [4 + 2] Cycloaddition.J Am Chem Soc2024https://conductscience.org/library/papers/39265189PubMed
37327570Heterologous Expression of the Formicamycin Biosynthetic Gene Cluster Unveils Glycosylated Fasamycin Congeners.J Nat Prod2023https://conductscience.org/library/papers/37327570PubMed
33092156Discovery of New Antibacterial Accramycins from a Genetic Variant of the Soil Bacterium, Streptomyces sp. MA37.Biomolecules2020https://conductscience.org/library/papers/33092156PubMed
32422934Mersaquinone, A New Tetracene Derivative from the Marine-Derived Streptomyces sp. EG1 Exhibiting Activity against Methicillin-Resistant Staphylococcus aureus (MRSA).Antibiotics (Basel)2020https://conductscience.org/library/papers/32422934PubMed
31533358Accramycin A, a New Aromatic Polyketide, from the Soil Bacterium, Streptomyces sp. MA37.Molecules2019https://conductscience.org/library/papers/31533358PubMed
28293036Naphthacemycins, novel circumventors of β-lactam resistance in MRSA, produced by Streptomyces sp. KB-3346-5. II. Structure elucidation.J Antibiot (Tokyo)2017https://conductscience.org/library/papers/28293036PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28293038

GET https://conductscience.org/api/papers/v1/28293038/authors